1 year return (CAGR)
21.18%
NRX Pharmaceuticals Inc Exchange (NASDAQ, USD)
NRXP
3.49
+0.09 (+2.65%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
12.53%
5 year return (CAGR)
-52.81%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
151.10M
Price/Sales
44.52
Ent value
158.75M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
6.98
EPS growth
60.14%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.37 |
| Daily high | 3.60 |
| Daily low | 3.35 |
| Daily Volume | 1.21M |
| All-time high | 627.10 |
| 1y analyst estimate | 38.25 |
| Beta | 2.18 |
| EPS (TTM) | -0.62 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NRXP | S&P500 | |
| Current price drop from All-time high | -99.44% | -2.19% |
| Highest price drop | -99.81% | -56.47% |
| Date of highest drop | 14 Nov 2024 | 9 Mar 2009 |
| Avg drop from high | -61.52% | -10.68% |
| Avg time to new high | 14 days | 12 days |
| Max time to new high | 1410 days | 1805 days |
News
